( February 19, 2025, 2:11 PM EST) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on Feb. 18 said the U.S. Patent Trial and Appeal Board (PTAB) did not err when it upheld an examiner’s rejection of multiple claims of a patent application for a treatment for the viral infection that causes COVID-19, but the panel partly disagreed with the PTAB and the examiner’s reasoning....